Log In
BCIQ
Print this Print this
 

ZED-101

  Manage Alerts
Collapse Summary General Information
Company Zedira GmbH
DescriptionTissue transglutaminase inhibitors
Molecular Target Transglutaminase (TGM)
Mechanism of ActionTransglutaminase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationCeliac disease
Indication DetailsTreat celiac disease
Regulatory Designation
PartnerDr. Falk Pharma GmbH

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today